Brief: Guided Therapeutics Q2 revenue $103,000 versus $201,000
12/08/2015 21:05
Aug 12 (Reuters) - Guided Therapeutics Inc GTHP.OB : * Reports second quarter 2015 financial results; closes $10 million deal * Q2 revenue $103,000 versus $201,000 * Says basic and diluted net loss per share attributable to common stockholders $0.03 * Source text for Eikon ID:nBw1f23WGa * Further company coverage GTHP.OB ((Bengaluru Newsroom; +1 646 223 8780))
Recent news on Guided Therapeutics
See all newsBrief: Guided Therapeutics Receives $700,000 Purchase Order And Initial Payment From New Chinese Distributor
Brief: Guided Therapeutics Signs Agreement To Begin Clinical Trial For Us FDA Approval
Brief: Guided Receives IRB Approval To Start Clinical Study For FDA Approval Of Luviva Advanced Cervical Scan
Brief: Guided Therapeutics Inc Have Applied To List Common Stock On Nasdaq Capital Market
Brief: Guided Therapeutics Says Replaces Convertible Note Facility And Significantly Reduces Dilution